What are the limitations of the HEMORR2HAGES?

While the HEMORR2HAGES is highly validated, it should not replace clinical judgment. OpiCalc provides the latest evidence-based limitations for the HEMORR2HAGES to ensure safe bedside use and optimal diagnostic accuracy.

How does the HEMORR2HAGES compare to other Cardiovascular scores?

The HEMORR2HAGES is a gold-standard diagnostic tool. OpiCalc provides side-by-side clinical guidance to help clinicians choose the most specific evidence-based tool for their patient's presentation.

Is the HEMORR2HAGES free to use?

Yes. OpiCalc provides the HEMORR2HAGES completely ad-free and optimized for mobile bedside use, ensuring you can calculate medical risk swiftly and without distraction.

HEMORR2HAGES

HEMORR2HAGES: Estimates bleeding risk in patients with atrial fibrillation. A score ≥4 indicates high risk (~10%+ annual bleeding rate).

Hepatic or Renal Disease

Cirrhosis, elevated bilirubin, or CrCl < 30 mL/min

Ethanol (Alcohol) Abuse

Current or recent history of excessive consumption

Malignancy

Active malignancy or recent treatment

Age > 75 Years

Reduced Platelet Count/Function

Platelets < 100k or on antiplatelet therapy

Rebleeding Risk+2 pts

Prior major bleed

Uncontrolled Hypertension

SBP > 160 mmHg currently

Anemia

Hct < 30% or Hb < 10 g/dL

Genetic Factors

CYP2C9*2 and/or *3, or other high-risk SNPs

Elevated Fall Risk

History of falls, gait instability, or frailty

Stroke History

Prior stroke, TIA, or thromboembolism

No clinical reference data available.